-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Receiving metformin treatment may improve the prognosis of patients with gastric adenocarcinoma, but the amount of existing literature is very limited and the results are conflicting.
Metformin
Recently, a research article was published in the British Journal of Cancer, an authoritative journal in the field of oncology.
Diagnose diabetes
The data for the study comes from four national health data registries: the prescription drug registry, the cancer registry, the patient registry, and the cause of death registry.
Cumulative mortality curve of metformin users and non-users
Through analysis, the researchers found that compared with non-metformin users, the disease-specific mortality (HR 0.
Metformin can improve the survival rate of diabetic patients with gastric adenocarcinoma
Original source:
Original source:Jiaojiao Zheng.